Durstenfeld MS

ORCID: 0000-0002-7612-3352 · 1 paper in corpus

rct 2026

SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial.

Nature communications ·doi:10.1038/s41467-026-77925-y

Persistence of SARS-CoV-2 has been proposed as a biological driver of Long COVID, a disabling chronic illness with no proven treatments. We conducted an exploratory, placebo-controlled, double-blind, 2:1 randomized mechanistic trial (NCT058…